We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
-3.33%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
-$59.5M
Cap. Flow
-$55M
Cap. Flow %
-47.12%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$267K

Top Sells

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$31.8M
2
CELL
PhenomeX Inc. Common Stock
CELL
+$11.7M
3
CTLT
CATALENT, INC.
CTLT
+$10.9M
4
AZTA icon
Azenta
AZTA
+$858K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZTA icon
1
Azenta
AZTA
$1.21B
$48.2M 41.3%
467,582
-7,912
-2% -$858K
CTLT
2
DELISTED
CATALENT, INC.
CTLT
$35M 29.99%
273,434
-84,869
-24% -$10.9M
CRL icon
3
Charles River Laboratories
CRL
$10.8B
$33.5M 28.7%
88,925
+686
+0.8% +$267K
BIO icon
4
Bio-Rad Laboratories Class A
BIO
$8.15B
– –
-42,679
Closed -$31.8M
CELL
5
DELISTED
PhenomeX Inc. Common Stock
CELL
– –
-596,802
Closed -$11.7M

Similar funds

RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM
SCM
Stamina Capital Management New York $13.3M AUM 71.17% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Tower House Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Tower House Partners held 5 positions worth $117M, down 34% from $176M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tower House Partners withdrew a net $55M in Q4 2021, closing 2 positions and reducing 2 holdings. Its most notable exit was Bio-Rad Laboratories Class A, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Tower House Partners added an estimated $267K to Charles River Laboratories.

  • Tower House Partners added most to Charles River Laboratories in Q4 2021, an estimated $267K increase.
  • Tower House Partners's biggest Q4 2021 reduction was CATALENT, INC., cutting an estimated $10.9M.
  • Tower House Partners fully exited Bio-Rad Laboratories Class A in Q4 2021, selling an estimated $31.8M.
  • Tower House Partners's ten largest holdings make up 100% of its $117M portfolio in Q4 2021.
  • Tower House Partners opened 0 new positions and closed 2 in Q4 2021.
  • Tower House Partners's portfolio value fell 34% quarter-over-quarter to $117M.

Based on Tower House Partners's 13F filing for Q4 2021, filed 14 Feb 2022.